U.S. federal trademark · Serial No. 79222595 · Reg. No. 5592503
Pharmaceutical [ and veterinary ] products for the treatment of Wilson disease, metabolic and inherited liver disorders, viral and bacterial infections, bodily conditions associated with impaired immunosystems, single gene disorders, hemophilia, blood disorders, diseases of the nervous system, neuro-degenerative disorders, inflammatory and auto-immune diseases and disorders, metabolic system and endocrine system diseases and disorders [ ; immunosuppression pharmaceutical and veterinary products; sanitary preparations for medical purposes; Biological preparations for clinical medical use intended for gene therapy and cell therapy; Clinical medical reagents used for gene therapy, genetic testing and diagnosis; Cellular preparations for medical, pharmaceutical or veterinary use for gene therapy and cell therapy; Gene therapy products for the treatment of Wilson disease, metabolic and inherited liver disorders, viral and bacterial infections, bodily conditions associated with impaired immunosystems, single gene disorders, hemophilia, blood disorders, diseases of the nervous system, neuro-degenerative disorders, inflammatory and auto-immune diseases and disorders, metabolic system and endocrine system diseases and disorders; Immunosuppression gene therapy products ]
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.